SWAG · Stran & Company, Inc. · Insider Trading

Vests as to 1,508 shares on each of September 30, 2026, December 31, 2026, March 31, 2027, and June 30, 2027.

Vests as to 1,415 shares on each of September 30, 2026, December 31, 2026, March 31, 2027, and June 30, 2027.

Vests as to 1,508 shares on each of September 30, 2026, December 31, 2026, March 31, 2027, and June 30, 2027.

Vests as to 1,508 shares on each of September 30, 2026, December 31, 2026, March 31, 2027, and June 30, 2027.

Vests as to 2,362 shares on each of September 30, 2025, December 31, 2025, and March 31, 2026, and as to 2,363 shares on June 30, 2026.

Vests as to 2,500 shares on each of September 30, 2025, December 31, 2025, March 31, 2026, and June 30, 2026.

On April 14, 2023, Josselin Capital Advisors, Inc. ("JCA"), of which the reporting person is the sole principal and stockholder, was granted 46,511 shares of common stock that are subject to vesting based on the issuer's attainment of certain performance conditions for the fiscal year ended December 31, 2023. On June 29, 2023, the shares were distributed by JCA to the reporting person and are now owned by the reporting person directly. On February 15, 2024, the Compensation Committee of the board of directors of the issuer determined that the performance conditions had been met for the vesting of 2,339 of these shares.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.0850 to $1.1000, inclusive. The reporting person undertakes to provide to Stran & Company, Inc., any security holder of Stran & Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.4996 to $1.5200, inclusive. The reporting person undertakes to provide to Stran & Company, Inc., any security holder of Stran & Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.4600 to $1.5000, inclusive. The reporting person undertakes to provide to Stran & Company, Inc., any security holder of Stran & Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.4300 to $1.4983, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Stran & Company, Inc. (the "Issuer"), or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 2 to this Form 4.

Includes 80,000 shares of common stock previously granted to and held through Josselin Capital Advisors, Inc. ("JCA"), of which the reporting person is the sole owner, officer and director, which were distributed to the reporting person on June 29, 2023 and are now owned by the reporting person directly.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.4490 to $1.4700, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Stran & Company, Inc. (the "Issuer"), or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 2 to this Form 4.

On March 11, 2022, the reporting person was granted 5,000 shares of common stock and an option to purchase 40,000 shares for $1.60 per share, 5,000 of which vested and became exercisable immediately. Both the common stock and stock option were subject to a separate restriction on transfer which lapsed on September 11, 2022. The remaining 35,000 shares of common stock under the stock option vest subject to the issuer's attainment of certain performance-based conditions. On April 14, 2023, the Compensation Committee of the issuer determined that the performance-based conditions had been met for the vesting of the option as to 5,000 shares.

On December 6, 2021, the reporting person was granted 62,500 shares of restricted common stock subject to vesting conditions. One-eighth of the 62,500 shares of restricted stock vests at the end of every full quarter following their grant effective as of December 6, 2021 that the reporting person is employed by the issuer.

On December 6, 2021, the reporting person was granted an option to purchase 125,000 shares for $4.72 per share. The option vests and becomes exercisable as to one-eighth of 62,500 of the shares of common stock under the option at the end of each full quarter following December 6, 2021, subject to a separate restriction on transfer which lapsed on June 30, 2022. The stock option vests and becomes exercisable as to 40,000 shares subject to the issuer's attainment of certain respective performance-based conditions. The stock option vests and becomes exercisable as to 22,500 shares subject to the reporting person's satisfaction of certain respective service-based conditions. On April 14, 2023, the Compensation Committee of the issuer determined that the performance-based conditions under the option had been met for the vesting of the option as to 10,000 shares, and that the service-based conditions under the option had been met for the vesting of the option as to 2,500 shares.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.2600 to $1.2800, inclusive. The reporting person undertakes to provide to Stran & Company, Inc., any security holder of Stran & Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.3585 to $1.3699, inclusive. The reporting person undertakes to provide to Stran & Company, Inc., any security holder of Stran & Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.745 to $1.76, inclusive. The reporting person undertakes to provide to Stran & Company, Inc., any security holder of Stran & Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.7481 to $1.7899, inclusive. The reporting person undertakes to provide to Stran & Company, Inc., any security holder of Stran & Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.73 to $1.80, inclusive. The reporting person undertakes to provide to Stran & Company, Inc., any security holder of Stran & Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

On December 2, 2021, Josselin Capital Advisors, Inc. ("JCA"), over which the reporting person has voting and investment control, was granted an option to purchase 65,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria by Stran & Company, Inc. (the "Issuer"). On the same date, JCA also became entitled to awards of up to 60,000 shares of common stock subject to the satisfaction of certain performance criteria by the Issuer. On March 11, 2022, the Compensation Committee of the Board of Directors of the Issuer determined that the performance criteria for the vesting of the option as to a total of 20,000 shares of common stock and to the award of 20,000 shares of common stock had been met, resulting in vesting of the option as to 20,000 shares and the award of 20,000 shares of common stock to JCA.

On December 2, 2021, Josselin Capital Advisors, Inc. ("JCA"), over which the reporting person has voting and investment control, was granted an option to purchase 65,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria by Stran & Company, Inc. (the "Issuer"). On the same date, JCA also became entitled to awards of up to 60,000 shares of common stock subject to the satisfaction of certain performance criteria by the Issuer. On March 11, 2022, the Compensation Committee of the Board of Directors of the Issuer determined that the performance criteria for the vesting of the option as to a total of 20,000 shares of common stock and to the award of 20,000 shares of common stock had been met, resulting in vesting of the option as to 20,000 shares and the award of 20,000 shares of common stock to JCA.

Subject to vesting over a three-month period with all shares vesting on the three-month anniversary of the date of grant.

Includes 10,000 shares of common stock directly owned by the reporting person and 20,000 shares of common stock indirectly beneficially owned by the reporting person.

Vest in four (4) equal quarterly installments commencing in the first quarter following the effectiveness date of the registration statement for the issuer's initial public offering.